These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 618907)

  • 41. Quantitative prediction of erythrocyte sickling for the development of advanced sickle cell therapies.
    Lu L; Li Z; Li H; Li X; Vekilov PG; Karniadakis GE
    Sci Adv; 2019 Aug; 5(8):eaax3905. PubMed ID: 31457104
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Blockade of adhesion of sickle cells to endothelium by monoclonal antibodies.
    Hebbel RP
    N Engl J Med; 2000 Jun; 342(25):1910-2. PubMed ID: 10861330
    [No Abstract]   [Full Text] [Related]  

  • 43. Effect of cetiedil on erythrocyte sickling: new type of antisickling agent that may affect erythrocyte membranes.
    Asakura T; Ohnishi ST; Adachi K; Ozguc M; Hashimoto K; Singer M; Russell MO; Schwartz E
    Proc Natl Acad Sci U S A; 1980 May; 77(5):2955-9. PubMed ID: 6930678
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Enhanced survival of sickle erythrocytes upon treatment with glyceraldehyde.
    Benjamin LJ; Manning JM
    Blood; 1986 Feb; 67(2):544-6. PubMed ID: 3942837
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Membrane modifiers in sickle cell disease.
    Benjamin LJ
    Ann N Y Acad Sci; 1989; 565():247-61. PubMed ID: 2672964
    [No Abstract]   [Full Text] [Related]  

  • 46. Deoxyhemoglobin S: solubility vs. erythrocyte sickling.
    Vedvick TS; Koenig HM; Itano HA
    Clin Biochem; 1975 Aug; 8(4):288-90. PubMed ID: 1157297
    [No Abstract]   [Full Text] [Related]  

  • 47. Dimethyl adipimidate: a new antisickling agent.
    Lubin BH; Pena V; Mentzer WC; Bymun E; Bradley TB; Packer L
    Proc Natl Acad Sci U S A; 1975 Jan; 72(1):43-6. PubMed ID: 1054514
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Physiologic and rheologic effects of the antisickling agent ethacrynic acid and its N-butylated derivative on normal and sickle erythrocytes.
    Orringer EP; Blythe DS; Whitney JA; Brockenbrough S; Abraham DJ
    Am J Hematol; 1992 Jan; 39(1):39-44. PubMed ID: 1536139
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Enhanced erythrocyte apoptosis in sickle cell anemia, thalassemia and glucose-6-phosphate dehydrogenase deficiency.
    Lang KS; Roll B; Myssina S; Schittenhelm M; Scheel-Walter HG; Kanz L; Fritz J; Lang F; Huber SM; Wieder T
    Cell Physiol Biochem; 2002; 12(5-6):365-72. PubMed ID: 12438773
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vitro effects of aged garlic extract and other nutritional supplements on sickle erythrocytes.
    Ohnishi ST; Ohnishi T
    J Nutr; 2001 Mar; 131(3s):1085S-92S. PubMed ID: 11238822
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease.
    De Franceschi L; Bachir D; Galacteros F; Tchernia G; Cynober T; Alper S; Platt O; Beuzard Y; Brugnara C
    J Clin Invest; 1997 Oct; 100(7):1847-52. PubMed ID: 9312186
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hydergine and vincamine derivative LD 4298 exhibit no anti-sickling properties in vitro.
    Roth E; Elbaum D; Godoy E; Nagel RL
    Nouv Rev Fr Hematol (1978); 1979 Jan; 20(4):611-9. PubMed ID: 440964
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro.
    Cerami A; Manning JM
    Proc Natl Acad Sci U S A; 1971 Jun; 68(6):1180-3. PubMed ID: 5288366
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro inhibition of the rate of erythrocyte sickling by RMI 11,071A and its possible mechanism.
    MacKenzie RD; Gleason EM; Schatzman GL; Cawein MJ
    Proc Soc Exp Biol Med; 1979 Oct; 162(1):224-6. PubMed ID: 504233
    [No Abstract]   [Full Text] [Related]  

  • 55. Effects of piracetam and iodoacetamide on erythrocyte sickling.
    Costa FF; Zago MA; Bottura C
    Lancet; 1979 Dec; 2(8155):1302. PubMed ID: 93216
    [No Abstract]   [Full Text] [Related]  

  • 56. Prostaglandin oligomeric derivatives inhibit in vitro formation of dehydrated cells from sickle red cells.
    Ohnishi ST; Katsuoka M
    Prostaglandins Leukot Essent Fatty Acids; 1989 Sep; 37(3):197-201. PubMed ID: 2481856
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hypoxia activates a Ca2+-permeable cation conductance sensitive to carbon monoxide and to GsMTx-4 in human and mouse sickle erythrocytes.
    Vandorpe DH; Xu C; Shmukler BE; Otterbein LE; Trudel M; Sachs F; Gottlieb PA; Brugnara C; Alper SL
    PLoS One; 2010 Jan; 5(1):e8732. PubMed ID: 20090940
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of etidronate disodium on filterability of sickle cell erythrocytes.
    Van Duzee BF; Sunberg RJ; Benedict JJ
    J Pharm Sci; 1980 May; 69(5):599-600. PubMed ID: 6770074
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of erythrocyte sickling by cystamine, a thiol reagent.
    Hassan W; Beuzard Y; Rosa J
    Proc Natl Acad Sci U S A; 1976 Sep; 73(9):3288-92. PubMed ID: 135260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Static and dynamic rigidities of normal and sickle erythrocytes. Major influence of cell hemoglobin concentration.
    Evans E; Mohandas N; Leung A
    J Clin Invest; 1984 Feb; 73(2):477-88. PubMed ID: 6699172
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.